The Supreme Court ruled unanimously on Thursday, June 14, to return to the 2nd Circuit Court of Appeals a case brought in 2005 by Texas-based Animal Science Products Inc and New Jersey-based The Ranis Co Inc who accused Hebei Welcome Pharmaceutical and North China Pharmaceutical Group and other Chinese vitamin C makers of antitrust violations. A jury trial in 2013 resulted in the plaintiffs being awarded US$147 million in damages, but its ruling was overturrned by the 2nd Circuit on grounds that the court should have deferred to Chinese law as interpreted by that country’s government.
Featured News
NY Laws Requires Disclosure of AI Actors in Ads, Limit Use of Person’s Image After Death
Dec 12, 2025 by
CPI
Three More States to Throw the Switch on Comprehensive Privacy Rules in 2026.
Dec 12, 2025 by
CPI
Dozens of State AGs Demand AI Companies Fix ‘Delusion’ Outputs by Chatbots
Dec 11, 2025 by
CPI
Texas Sues Epic Systems, Accusing Health-Tech Giant of Anticompetitive Data Practices
Dec 11, 2025 by
CPI
Court Affirms Apple Injunction but Trims Limits in Epic Dispute
Dec 11, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Acqui-hiring
Dec 11, 2025 by
CPI
Anticompetitive Effects of Acquihires: Labor and Product Markets
Dec 11, 2025 by
Heski Bar-Isaac, Justin Johnson & Volker Nocke
Acquihires In the Technology Sector: Antitrust Scrutiny Through the Lens of Economics
Dec 11, 2025 by
Juliette Caminade, Rebecca Kirk Fair, Zsolt Udvari & Jeanne Vellard Smith
M&A in the AI Era: Considerations for Acquihiring
Dec 11, 2025 by
Ingrid Vandenborre, Kenneth Schwartz, Christopher Barlow, Page Griffin, Michael Cardella, Stuart Levi, Taylor Votek, Benjamin Salzer, Lisa G. Liu & Liz Kraus
Lock Them Up, or Take No Prisoners? Merger Policy and Acquiring AI Talent: Human Rights and Other Inconvenient Facts
Dec 11, 2025 by
Simon R. Pritchard